Eijiro Omoto

2.0k citations
45 papers · 1.3k indexed · 1 hit paper · h-index 14

Eijiro Omoto

44 papers receiving 1.2k citations

Hit Papers

Prognostic implication of FLT3 and N-RAS gene mutations i...6201999202620082017200400600

Peers

Eijiro Omoto
Comparison fields: 5 of 87
  • Hematology 900
  • Genetics 311
  • Microbiology 11
  • Immunology 165
  • Molecular Biology 535
Replace Inger Marie S. Dahl with:
Inger Marie S. Dahl Norway
Tomas Ahlgren Sweden
JR Testa United States
Gianluigi Castoldi Italy
Fumiharu Yagasaki Japan
Yataro Yoshida Japan
Christina Boulton United States
Ingunn Dybedal Norway
H. Pralle Germany
WJ Miller United States
Eijiro Omoto relative to Inger Marie S. Dahl Norway Inger Marie S. Dahl's profile →
Citations per field
00.5×1.5×
Inger Marie S. Dahl · 1×
Citations per year

Countries citing papers authored by Eijiro Omoto

Since Specialization
Citations

This map shows the geographic impact of Eijiro Omoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eijiro Omoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eijiro Omoto more than expected).

Fields of papers citing papers by Eijiro Omoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eijiro Omoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eijiro Omoto. The network helps show where Eijiro Omoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eijiro Omoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eijiro Omoto Line = papers co-authored together Eijiro Omoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20221
2 20150
3 20038
4 200120
5 200047
6 199923
7 199818
8 199815
9 199773
10 19976
11 19973
12 1997185
13 19973
14 199713
15 19924
16 199134
17 19905
18 199010
19 19894
20
Purification and characterization of ceruloplasmin receptors.
19892

About Eijiro Omoto

Eijiro Omoto is a scholar working on Microbiology, Hematology and Genetics, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (10 papers), Retinoids in leukemia and cellular processes (4 papers), Immunotherapy and Immune Responses (4 papers), Mesenchymal stem cell research (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Hematology (900 citations), Genetics (311 citations) and Microbiology (11 citations). Eijiro Omoto has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Ryuzo Ohno, Kenji Saito, Norio Asou, Kazutaka Kuriyama, Shuichi Miyawaki, Ryuzo Ueda, Toshiko Motoji, Chihiro Shimazaki, Itsuro Jinnai and Yasuyuki Nakano. Their work appears in journals such as Blood, Annals of Hematology, British Journal of Haematology, Bone Marrow Transplantation and Pathobiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026